Comment on: Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database.

HOME
>
論文・技術情報
>
Comment on: Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database.

アブストラクト
ジャーナル名	Therapeutic advances in neurological disorders
Pubmed追加日	2024/9/18
投稿者	Khouri, Charles; Hlavaty, Alex; Revol, Bruno; Salvo, Francesco; Raschi, Emanuel
組織名	Pharmacovigilance Unit, Grenoble Alpes University Hospital, Universite Grenoble;Alpes, F-38000 Grenoble, France.;HP2, Inserm U1300, Universite Grenoble Alpes, Grenoble, France.;Alpes, Grenoble, France.;INSERM, BPH, Team AHeaD, U1219, Universite de Bordeaux, Bordeaux, France.;Service de Pharmacologie Medicale, CHU de Bordeaux, INSERM, U1219, Bordeaux,;France.;Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of;Bologna, Bologna, Italy.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/39290528/